Year: 2021
Type: review
Abstract: Metabolic perturbations underlie a variety of cardiovascular disease states; yet, metabolic interventions to prevent or treat these disorders are sparse. Ketones carry a negative clinical stigma as they are involved in diabetic ketoacidosis. However, evidence from both experimental and clinical research has uncovered a protective role for ketones in cardiovascular disease. Although ketones may provide supplemental fuel for the energy-starved heart, their cardiovascular effects appear to extend far beyond cardiac energetics. Indeed, ketone bodies have been shown to influence a variety of cellular processes including gene transcription, inflammation and oxidative stress, endothelial function, cardiac remodeling, and cardiovascular risk factors. This paper reviews the bioenergetic and pleiotropic effects of ketone bodies that could potentially contribute to its cardiovascular benefits based on evidence from animal and human studies.
Language: English
Topic: Diet and metabolism studies
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,600
Funders: Amgen, Pfizer, Roche, National Heart Foundation of Australia, Hartstichting, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, European Research Council, National Health and Medical Research Council, National Heart, Lung, and Blood Institute, Janssen Pharmaceuticals
Awards: Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart, G3551288255, Targeting Ketone Metabolism as a Novel Heart Failure Therapy, G5765034704, G717588951, Novel strategy to prevent cardiovascular complications in diabetes: the role of poly(ADP-ribose) polymerase-1 inhibition, Probing the Cardiac PGC-1 Regulatory Cascade, G8062521229
OpenAlex ID: W3129301210
